An update from Innovative Pharmaceutical Biotech ( (HK:0399) ) is now available.
Innovative Pharmaceutical Biotech Limited announced the resignation of Mr. Cheng Tak Yiu as an executive director, effective March 4, 2025. Mr. Cheng resigned to focus on personal business engagements, and his departure is amicable, with no disagreements reported. The company expressed gratitude for his contributions, and this change is not expected to impact its operations or market position.
More about Innovative Pharmaceutical Biotech
Innovative Pharmaceutical Biotech Limited operates in the pharmaceutical and biotechnology industry, focusing on developing innovative medical solutions and biotechnological advancements.
YTD Price Performance: -14.29%
Average Trading Volume: 1,091,727
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$328M
Learn more about 0399 stock on TipRanks’ Stock Analysis page.